DARZALEX  FASPRO ®   U.S. Prescribing Information. 2 Johnson & Johnson Innovative Medicine. DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based quadruplet ...

Quadruplet regimen demonstrated significantly deeper and more durable responses, higher MRD negativity and improved progression-free survival versus a standard of care?

United Therapeutics reported revenues of $799.5 million, up 6.8% year on year, falling short of analysts’ expectations by 1.6 ...

Detailed price information for United Therapeutic (UTHR-Q) from The Globe and Mail including charting and trades.

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

New study shows how bacteria adapted a virus-derived injection system to recognize and attach to many different types of ...

From life-saving vaccines to advanced cancer therapies, biopharmaceuticals are quietly transforming modern medicine. Made ...

A curious phenomenon seen by oncologists, that morning patients do better than those receiving afternoon infusions, gains ...

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

Infusion therapies can be "life changing" for those suffering from chronic illnesses, founder Shaya Fogel said.